Keppra 500mg ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
13Multiple sclerosis/Neuromyelitis optica1

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,342 Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-003903-35-GB
(EUCTR)
19/01/200619/12/2005 : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis Multiple SclerosisTrade Name: Keppra 250mg
INN or Proposed INN: Levetiracetam
Trade Name: Keppra 500mg
Product Name: Keppra ®
Newcastle-upon-Tyne Hospitals NHS TrustNULLNot Recruiting Female: yes
Male: yes
20 Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yesUnited Kingdom